Tag: dual immunotherapy

Radiographic surrogates may predict tumor-specific survival in renal carcinoma

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

byDaniel Goldshteinand1 others

May 23, 2023

1. The probability of progression-free survival at 12 months was 0.57 in the experimental group (cabozantinib plus nivolumab and ipilimumab) ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Less frequent mammography is non-inferior to annual screening for breast cancer survival in women after curative treatment
#VisualAbstract: Inhaled Sedation Does Not Improve Clinical Outcomes in Acute Respiratory Distress Syndrome
4:3 intermittent fasting effective for weight loss among adults with obesity

No Result

View All Result